Some meta-analyses and prospective studies have concluded that 5-HT transporter linked promoter region (5-HTTLPR) polymorphisms may significantly impact the risk of depression in CHD patients (25–29). The gene discussed is SLC6A4; the disease is depressive symptom measurement.